This project was retrospective in design with 2 phases of review. The first phase comprised data collection 6 weeks before the addition of the ESS in the EMR (time 1) and 6 weeks after the ESS was ...
Use of a modified sleep apnea index can identify cardiovascular risk factors in adults with moderate to severe obstructive sleep apnea (OSA), according to results from a new study presented at the ...
If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA ...
After patients are flagged as high risk by the ESS tool (a score of ≥10), the clinician can then refer the patient for a sleep study, on the basis of which continuous positive airway pressure therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results